NEW YORK, Aug. 28, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
The Pharmaceutical Market: China
http://www.reportlinker.com/p0203118/The-Pharmaceutical-Market-China.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:
Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators.
Specialised intelligence on OTCs, generics, biologics and biosimilars.
Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series.
A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel.
The reports are updated quarterly, providing you with the latest information for a full year. In addition, the service will keep you up to date with market and industry news on a regular basis.
TABLE OF CONTENTS
EXECUTIVE SUMMARY 1
Snapshot: Strategic Espicom Analysis 2
Snapshot: Key Data Projections3
MACROENVIRONMENT 4
POLITICAL 4
ECONOMIC 5
Projections 5
Government's Revaluation of CNY 6
LEGAL 6
Administrative Protection 7
USTR Status 7
DEMOGRAPHIC 8
Projections 8
Current Figures 9
Demographic Indicators 9
Births 9
Deaths 9
Infant Deaths 9
Life Expectancy at Birth 9
EPIDEMIOLOGY 10
DISEASE BURDEN 10
Leading Causes of Mortality 10
DISEASE PREVALENCE11
Communicable Diseases 11
HIV/AIDS 11
Non-communicable Diseases 12
Diabetes 12
HEALTHCARE - ACCOMPANYING HEALTH STATISTICS 13
ORGANISATION 13
Healthcare Reform Plan 13
Ministry of Health13
Hospitals 13
Rural Healthcare 14
Red Cross Society of China 14
EXPENDITURE 15
Projections 15
Latest Figures 16
Health Insurance 16
Public Health Insurance 16
Private Health Insurance 18
INFRASTRUCTURE 18
Hospital Infrastructure18
Outpatient Infrastructure 19
SERVICES 20
Inpatient Analysis20
Outpatient Analysis 21
WORKFORCE 22
Projections 22
Current State 23
REGULATORY AFFAIRS 24
NATIONAL AUTHORITY 24
Department of Drug Registration24
REGULATORY DEVELOPMENTS 24
SFDA Starts Overseas Factory Inspections 24
Revised GMP Regulations 25
Revised Antibiotic Regulations 25
MARKETING REGISTRATION 25
Department of Drug Safety & Inspection 26
Department of Drug Market Compliance 26
Drug Classification 27
Regulatory Legislation27
2001 DAL Amendments 27
Drug Import Regulation 28
GMP Regulations 28
Drug Approval Process 28
Clinical Trials28
Quality Tests29
Certification 29
PACKAGING 29
POST-MARKETING SURVEILLANCE 30
Revoked Licences30
Bribery Cases 30
PROMOTION 30
Advertising 30
PRICING & REIMBURSEMENT 31
PRICING 31
National Pricing31
REIMBURSEMENT 32
DISTRIBUTION CHANNELS 34
DRUG WHOLESALING 34
Selected Wholesalers35
Alliance Boots35
China Medical System 35
Chindex 35
First China Pharmaceutical Group 36
Global Pharm Holdings Group 37
Guangzhou Pharmaceutical 37
Hutchison China MediTech 38
Jointown Pharmaceutical Group 38
Nanjing Pharmaceutical 39
Shanghai Pharmaceuticals 39
Sinopharm40
DRUG RETAILING42
Selected Pharmacy Chains42
China BCT Pharmacy Group 42
ShenZhen Nepstar 42
MARKET ANALYSIS 43
SIZE 43
Projections 43
Historical Figures 45
Current Structure 46
PRODUCT DEVELOPMENT 48
12th Five-Year Plan 2011-2015 48
Mega New Drug Development Programme 48
SFDA R&D Initiatives 48
Beijing Economic-Technological Development Area49
Zhangjiang Hi-Tech Park 49
MANUFACTURING 50
China to Turn Five Companies into International Producers 52
TRADE52
Exports 52
Imports 55
Balance of Trade 59
COMPETITION 61
TRADE ASSOCIATIONS 61
CAPC61
CCCMHPIE 61
CPIA 61
RDPAC 62
TRADE FAIRS 63
Interphex China63
PharmChina 63
COMPANY INTELLIGENCE 64
Foreign Manufacturers64
Astellas Pharma64
AstraZeneca64
Boehringer Ingelheim 65
Bristol-Myers Squibb66
Daiichi Sankyo 66
Dainippon Sumitomo Pharma 67
Dragon Pharmaceuticals 67
Eisai68
Eli Lilly 68
GlaxoSmithKline 69
Johnson & Johnson69
Merck KGaA 70
Merck Sharp & Dohme70
Mitsubishi Tanabe Pharma 71
Novartis 71
Novo Nordisk 72
Pfizer 73
Roche 74
Sanofi 74
SciClone 75
Servier 76
Shionogi 76
Takeda 77
Local Manufacturers 78
Beijing Double-Crane Pharmaceutical79
China Pharmaceutical Group 80
Harbin Pharmaceutical Group 81
Joincare Pharmaceutical Group 82
North China Pharmaceutical 82
Shanghai Pharmaceuticals 83
Tianjin Tasly Pharmaceutical 84
The United Laboratories International 85
Zhejiang Hisun Pharmaceutical86
Zhejiang Medicine 87
OTC PHARMACEUTICALS 89
REGULATION 89
MARKET SIZE 89
COMPETITION 90
Trade Association90
CNMA90
Foreign Company Intelligence90
Sanofi90
Local Company Intelligence 90
China Sky One Medical90
GENERIC PHARMACEUTICALS 92
REGULATION 92
Prescribing Regulation92
MARKET SIZE 92
COMPETITION 92
Foreign Company Intelligence92
AstraZeneca 92
Sandoz 92
Watson93
Local Company Intelligence 93
China Pharma 93
Qilu Pharmaceutical 94
Shanghai Fosun Pharmaceutical 95
BIOLOGICS & BIOSIMILARS 96
REGULATION 96
MARKET SIZE 96
PRODUCT DEVELOPMENT 96
COMPETITION 97
Foreign Company Intelligence97
GlaxoSmithKline 97
Microbix 97
NeoStem97
Sanofi98
Local Company Intelligence 99
3SBIO99
Anhui Anke Biotech100
Beijing SL Pharmaceutical 101
China Biologic Products 102
Harbin Gloria Pharmaceuticals 103
Kun Run Biotechnology 103
Lanzhou Institute of Biological Products103
Livzon Pharmaceutical Group 104
Nuokang Bio-Pharmaceutical 105
Shenzhen Hepalink Pharmaceutical 106
Simcere Pharmaceutical Group 107
Sinovac Biotech 108
Walvax Biotechnology 110
WuXi PharmaTech 110
CONCLUSIONS: OPPORTUNITIES & CHALLENGES112
Strategic Espicom Analysis 112
MACROENVIRONMENT 112
EPIDEMIOLOGY 112
HEALTHCARE 113
REGULATORY AFFAIRS 113
PRICING & REIMBURSEMENT 114
DISTRIBUTION CHANNELS 114
MARKET 114
COMPETITION 115
OTC PHARMACEUTICALS 115
GENERIC PHARMACEUTICALS116
BIOLOGICS & BIOSIMILARS 116
Radar Analysis 118
SWOT Analysis 118
DIRECTORY 119
GOVERNMENT ORGANISATIONS 119
PHARMACEUTICAL DISTRIBUTORS119
Pharmaceutical Wholesalers 119
Pharmaceutical Retailers 119
PHARMACEUTICAL MANUFACTURERS119
Foreign Pharmaceutical Manufacturers119
Local Pharmaceutical Manufacturers 120
Foreign OTC Manufacturer 120
Local OTC Manufacturer 120
Foreign Generic Manufacturers 120
Local Generic Manufacturers120
Foreign Biologic Manufacturers 120
Local Biologic Manufacturers121
TRADE ORGANISATIONS121
List of Tables
Espicom Analysis of the Pharmaceutical Market, 2012 2
Key Data Projections, 2012-2017 3
Political Landscape, 2012 4
Regional Ranking of Projected Economies, 2017 5
Projected Economy, 2012-2017 5
Regional Ranking of Projected Demographics, 2017 8
Projected Demographics, 2012-2017 8
Demographic Indicators, 2004-2010 9
Leading Causes of Death, 2010 10
Reported Infectious Diseases, 2001-2010 (Rate/100,000 Population) 11
Regional Ranking of Projected Health Expenditure, 2017 15
Projected Health Expenditure, 2012-201715
Healthcare Expenditure by Type, 2000-2009 (CNY Billions) 16
Hospitals, 2000-2008 18
Hospitals by Region & Municipality, 2008 18
Outpatient Institutions by Type, 2001-2008 19
Health Centres & Clinics by Region & Municipality, 2008 19
Inpatient Admissions, 2002-2008 (Millions) 20 Inpatient Admissions by Type & Institution, 2008 (10,000s) 20
Outpatient Visits, 1999-2008 (Millions) 21
Outpatient Visits by Type & Institution, 2008 (Millions) 21
Regional Ranking of Projected Physicians, 2017 22
Projected Physicians, 2012-2017 22
Medical Personnel by Type, 2008 (000s) 23
Physicians by Region & Municipality, 2008 (000s) 23
Chindex Operating Results, 2006-2010 (US$ 000s) 35
Chindex Revenue by Business Segment, 2006-2010 (US$000s) 36
First China Pharmaceutical Group Operating Results, 2010-2011 (US$ 000s) 36
Guangzhou Pharmaceutical Operating Results, 2007-2011 (CNY 000s) 37
Hutchison China MediTech Operating Results, 2006-2010 (US$ 000s) 38
Jointown Pharmaceutical Group Operating Results, 2007-2010 (CNY 000s) 39
Nanjing Pharmaceutical Operating Results, 2006-2010 (CNY 000s) 39
Shanghai Pharmaceuticals Revenue by Business Segment, 2009-2010 (CNY 000s) 40
Sinopharm Operating Results, 2006-2010 (CNY 000s) 41
Sinopharm Revenue by Business Segment, 2006-2010 (CNY 000s) 41
Regional Ranking of Projected Pharmaceutical Markets, 2017 43
Projected Pharmaceutical Market at Retail Prices, 2012-2017 45
Historical Pharmaceutical Market at Retail Prices, 1995-2011 45
Pharmaceutical Sales at Retail Prices, 2000-2011 (CNY Billions)46
Pharmaceutical Sales by Sector, 2009-2010 (CNY Billions) 47
Pharmaceutical & Medical Device Output, 1998-2011 (CNY Billions) 50
Pharmaceutical & Medical Device Output by Type, 2010 (CNY Billions) 51
Pharmaceutical Exports by Category, 1995-2010 (US$000s) 52
Pharmaceutical Exports by Country/Region, 2010 (US$000s) 54
Pharmaceutical Imports by Category, 1995-2010 (US$000s) 55
Imports of Raw Materials by Country/Region, 2010 (US$000s) 57
Imports of Antisera & Vaccines by Country/Region, 2010 (US$000s) 57
Imports of Medicaments by Country/Region, 2010 (US$000s) 58
Pharmaceutical Balance of Trade, 1995-2010 (US$000s) 59
RDPAC Members, 2011 62
AstraZeneca Revenue by Country, 2006-2010 (US$ 000s) 64
Dainippon Sumitomo Pharma Revenue, 2010 (¥ 000s) 67
Eisai Revenue by Country, 2009-2010 (¥ 000s)68
Merck KGaA Revenue by Country & Type, 2010-2011 (€ 000s) 70
Novo Nordisk Revenue by Country, 2006-2010 (DKK 000s) 72
Sanofi Revenue by Country, 2010 (€ 000s) 75
SciClone Revenue, 2006-2010 (US$ 000s) 76
Top 25 Local Pharmaceutical Manufacturers by Revenue, 2010 (US$ 000s) 78
Beijing Double-Crane Pharmaceutical Operating Results, 2006-2010 (CNY 000s) 79
China Pharmaceutical Group Operating Results, 2006-2010 (HK$ 000s) 80
China Pharmaceutical Group Revenue by Geographical Area, 2006-2010 (HK$ 000s) 80
China Pharmaceutical Group Revenue by Business Segment, 2006-2010 (HK$ 000s) 81
Harbin Pharmaceutical Group Operating Results, 2006-2010 (CNY 000s) 81
Joincare Pharmaceutical Group Operating Results, 2006-2010 (CNY 000s) 82
North China Pharmaceutical Operating Results, 2006-2010 (CNY 000s) 83
Shanghai Pharmaceuticals Revenue by Business Segment & Drug Type, 2009-2010 (CNY 000s) 84
Tianjin Tasly Pharmaceutical Operating Results, 2006-2010 (CNY 000s) 84
The United Laboratories International Operating Results, 2006-2010 (HK$ 000s) 85
The United Laboratories International Revenue by Geographical Area, 2006-2010 (HK$ 000s) 85
The United Laboratories International Revenue by Business Segment, 2006-2010 (HK$ 000s) 86
Zhejiang Hisun Pharmaceutical Operating Results, 2006-2010 (CNY 000s) 87
Zhejiang Medicine Operating Results, 2006-2010 (CNY 000s)88
OTC Pharmaceutical Sales, 2005-2009 (CNY Billions) 89
China Sky One Medical Operating Results, 2006-2010 (US$ 000s) 91
China Sky One Medical Revenue by Product Area, 2007-2010 (US$ 000s) 91
China Pharma Operating Results, 2007-2010 (US$ 000s) 93
China Pharma Revenue by Therapeutic Area, 2009-2010 (US$ 000s) 94
Shanghai Fosun Pharmaceutical Operating Results, 2007-2010 (CNY 000s) 95
Shanghai Fosun Pharmaceutical Revenue by Business Segment, 2007-2010 (CNY 000s) 95
NeoStem Operating Results, 2009-2010 (US$ 000s) 98
3SBIO Operating Results, 2006-2010 (CNY 000s) 99
3SBIO Foreign Revenue by Geographical Area, 2006-2010 (CNY 000s) 99
3SBIO Revenue by Product Type, 2006-2010 (CNY 000s) 100
Anhui Anke Biotech Operating Results, 2006-2010 (CNY 000s) 101
Beijing SL Pharmaceutical Operating Results, 2006-2010 (CNY 000s) 101
China Biologic Products Operating Results, 2006-2010 (US$ 000s) 102
China Biologic Products Revenue by Product Area, 2006-2010 (US$ 000s) 102
Harbin Gloria Pharmaceuticals Operating Results, 2007-2010 (CNY 000s) 103
Livzon Pharmaceutical Group Operating Results, 2006-2010 (CNY 000s) 104
Livzon Pharmaceutical Group Operating Income by Product Area, 2006-2010 (CNY 000s) 105
Nuokang Bio-Pharmaceutical Operating Results, 2008-2010 (CNY 000s) 106
Shenzhen Hepalink Pharmaceutical Operating Results, 2007-2010 (CNY 000s) 107
Simcere Pharmaceutical Group Operating Results, 2006-2010 (CNY 000s) 108
Sinovac Biotech Operating Results, 2006-2010 (US$ 000s) 109
Sinovac Biotech Revenue by Product Area, 2006-2010 (US$ 000s) 109
Walvax Biotechnology Operating Results, 2007-2010 (CNY 000s) 110
WuXi PharmaTech Operating Results, 2006-2010 (US$ 000s) 111
WuXi PharmaTech Revenue by Business Segment, 2006-2010 (US$ 000s)111
WuXi PharmaTech Revenue by Geographical Area, 2006-2010 (US$ 000s)111
Espicom Analysis of the Pharmaceutical Market, 2012 117
SWOT Analysis of the Pharmaceutical Market, 2012 118
List of Charts
Regional Comparison of Top 5 Projected Pharmaceutical Markets at Retail Prices, 2017 44
Regional Comparison of Projected Pharmaceutical Market Share, 2017 44
Historical Pharmaceutical Market at Retail Prices, 1995-201146
Pharmaceutical Sales at Retail Prices, 2000-2011 (CNY Billions) 47
Pharmaceutical & Medical Device Output, 1998-2011 (CNY Billions) 50
Pharmaceutical Exports, 1995-2010 (US$ Billions) 53
Pharmaceutical Imports, 1995-2010 (US$ Billions) 55
Pharmaceutical Imports by Country/Region, 2010 (%) 56
Pharmaceutical Balance of Trade, 1995-2010 (US$ Billions)60
OTC Pharmaceutical Sales, 2005-2009 (CNY Billions) 89
Radar Graph of the Pharmaceutical Market, 2012 118
To order this report:
Pharmaceutical Industry: The Pharmaceutical Market: China
Check our Industry Analysis and Insights
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article